Los Angeles Capital Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$16.78 - $31.94 $176,827 - $336,583	10,538 Added 75.38%	24,518 $734,000
Q3 2023 Nov 06, 2023	BUY	$15.07 - $24.05 $210,678 - $336,219	13,980 New	13,980 $286,000
Q4 2021 Feb 03, 2022	SELL	$21.52 - $36.02 $176,248 - $295,003	-8,190 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$39.41 - $47.25 $19,705 - $23,625	-500 Reduced 5.75%	8,190 $363,000
Q1 2021 May 05, 2021	SELL	$43.34 - $65.91 $72,161 - $109,740	-1,665 Reduced 16.08%	8,690 $385,000
Q4 2020 Feb 04, 2021	BUY	$23.3 - $59.57 $241,271 - $616,847	10,355 New	10,355 $568,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.